Literature DB >> 28815484

Diagnostic performance of a newly developed salivary cortisol and cortisone measurement using an LC-MS/MS method with simple and rapid sample preparation.

K Mészáros1,2,3, G Karvaly1,3, Z Márta4, B Magda4, J Tőke5, N Szücs5, M Tóth5, K Rácz5,6, A Patócs7,8,9.   

Abstract

BACKGROUND: Late-night salivary cortisol level is one of the first-line tests recommended by the Endocrine Society for the diagnosis of endogenous hypercortisolism. Most routine laboratories measure cortisol levels using immunoassay tests which fail to determine low cortisol levels accurately due to the numerous interfering substances. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with simple and rapid sample preparation was developed for the simultaneous measurement of cortisol and cortisone and its performance in the diagnosis of endogenous hypercortisolism was evaluated.
METHODS: 324 late-night saliva samples were analyzed from which 272 samples were derived from patients with a suspected diagnosis of endogenous hypercortisolism. Salivary cortisol levels were assayed using an electrochemiluminescent immunoassay (ECLIA, Cortisol II, Roche), and simultaneous measurement of cortisol and cortisone was performed using an LC-MS/MS method.
RESULTS: A strong correlation between cortisol results measured using ECLIA and LC-MS/MS (r 2 = 0.892) was demonstrated. Receiver operating characteristics (ROC) analysis showed good diagnostic performance of cortisol and cortisone levels assayed using LC-MS/MS method and for cortisol measured using ECLIA.
CONCLUSIONS: Late-night salivary cortisol and cortisone are useful parameters for the diagnosis of hypercortisolism. Using samples obtained from patients where the diagnosis of hypercortisolism is extremely challenging cut-off values for midnight salivary cortisol and cortisone measured by LC-MS/MS method were established.

Entities:  

Keywords:  Cortisol; Cortisone; ECLIA; Hypercortisolism; LC–MS/MS; Late-night saliva

Mesh:

Substances:

Year:  2017        PMID: 28815484     DOI: 10.1007/s40618-017-0743-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.

Authors:  P Magnisali; M-B Chalioti; T Livadara; M Mataragas; S Paliatsiou; A Malamitsi-Puchner; P Moutsatsou
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-04-04       Impact factor: 3.205

Review 2.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

3.  Salivary cortisone is a potential biomarker for serum free cortisol.

Authors:  I Perogamvros; B G Keevil; D W Ray; P J Trainer
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

4.  Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity.

Authors:  Stefan Z Lutz; Andreas Peter; Fausto Machicao; Apostolia Lamprinou; Jürgen Machann; Fritz Schick; Ingmar Königsrainer; Alfred Königsrainer; Andreas Fritsche; Harald Staiger; Hans-Ulrich Häring; Norbert Stefan; Konstantinos Kantartzis
Journal:  J Clin Endocrinol Metab       Date:  2016-10-07       Impact factor: 5.958

Review 5.  Cyclic Cushing's syndrome: a clinical challenge.

Authors:  J R Meinardi; B H R Wolffenbuttel; R P F Dullaart
Journal:  Eur J Endocrinol       Date:  2007-09       Impact factor: 6.664

6.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

7.  Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.

Authors:  Filippo Ceccato; Mattia Barbot; Marialuisa Zilio; Sergio Ferasin; Gianluca Occhi; Andrea Daniele; Sara Mazzocut; Maurizio Iacobone; Corrado Betterle; Franco Mantero; Carla Scaroni
Journal:  Eur J Endocrinol       Date:  2013-06-01       Impact factor: 6.664

8.  BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism.

Authors:  Agnes Szappanos; Attila Patócs; Judit Tõke; Belema Boyle; Márta Sereg; Judit Majnik; Gábor Borgulya; Ibolya Varga; István Likó; Károly Rácz; Miklós Tóth
Journal:  Clin Endocrinol (Oxf)       Date:  2009-01-22       Impact factor: 3.478

9.  Subclinical hypercortisolism among outpatients referred for osteoporosis.

Authors:  Iacopo Chiodini; Maria Lucia Mascia; Silvana Muscarella; Claudia Battista; Salvatore Minisola; Maura Arosio; Stefano Angelo Santini; Giuseppe Guglielmi; Vincenzo Carnevale; Alfredo Scillitani
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

10.  Simple liquid chromatography method for the rapid simultaneous determination of prednisolone and cortisol in plasma and urine using hydrophilic lipophilic balanced solid phase extraction cartridges.

Authors:  S AbuRuz; J Millership; L Heaney; J McElnay
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-12-25       Impact factor: 3.205

View more
  6 in total

1.  Measurement of urinary free cortisol by LC-MS-MS: adoption of a literature reference range and comparison with our current immunometric method.

Authors:  L Bianchi; B Campi; M R Sessa; G De Marco; E Ferrarini; R Zucchi; C Marcocci; P Vitti; L Manetti; A Saba; P Agretti
Journal:  J Endocrinol Invest       Date:  2019-04-22       Impact factor: 4.256

Review 2.  Autonomous cortisol secretion in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Miguel Antonio Sampedro Núñez; Mónica Marazuela
Journal:  Endocrine       Date:  2019-03-07       Impact factor: 3.633

3.  Bedtime Salivary Cortisol and Cortisone by LC-MS/MS in Healthy Adult Subjects: Evaluation of Sampling Time.

Authors:  Hershel Raff; Jonathan M Phillips
Journal:  J Endocr Soc       Date:  2019-06-26

4.  Three Dimensional Cell Culturing for Modeling Adrenal and Pituitary Tumors.

Authors:  Lilla Krokker; Borbála Szabó; Kinga Németh; Rebeka Tóháti; Balázs Sarkadi; Katalin Mészáros; Attila Patócs; Henriett Butz
Journal:  Pathol Oncol Res       Date:  2021-04-21       Impact factor: 3.201

5.  Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome.

Authors:  Joshua Kannankeril; Ty Carroll; James W Findling; Bradley Javorsky; Ian L Gunsolus; Jonathan Phillips; Hershel Raff
Journal:  J Endocr Soc       Date:  2020-07-24

Review 6.  Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?

Authors:  Gregori Casals; Felicia Alexandra Hanzu
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.